Skip to main content
. 2019 May 23;38:217. doi: 10.1186/s13046-019-1232-x

Fig. 1.

Fig. 1

Triptolide attenuates tumor development in AOM/DSS mice. a The workflow of the triptolide treatment in AOM/DSS-induced colitis-associated cancer (CAC) model. b Representative colons from control or triptolide-treated mice on day 80 of AOM/DSS induction. Scale bar: 1 cm. c Colon tumor number and size distribution from control or triptolide-treated. ** P < 0.01